One additional case of an invasive fungus resistant to antibiotics was reported at UK HealthCare after initial cases were reported in October, a spokesperson said Tuesday.
Candida auris is a pathogenic yeast fungus identified as an increasing threat. It can cause invasive infections in parts of the body like the bloodstream or respiratory tract, according to the Centers for Disease Control and Prevention. People can have the fungus present on their skin without becoming infected, the CDC said, and it is most likely to affect people who are already sick.
Five cases were reported at UK HealthCare last month, none of which were active infections. After UK announced the presence of the fungus, one additional case was identified, said UK spokesperson Allison Perry. That case did not turn into an infection.
In March, the CDC identified Candida auris as an increasing threat after it spread at a higher rate in American health care facilities in 2020-2021. In general, it is not a threat to people who are healthy, the CDC said. In 2021, the number of cases of the fungus that was resistant to echinocandins, the antifungal medicine most often recommended for treatment, tripled.
“CDC has deemed C. auris as an urgent (antimicrobial resistance) threat, because it is often resistant to multiple antifungal drugs, spreads easily in healthcare facilities, and can cause severe infections with high death rates,” according to the CDC.